Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Today on The Balancing Act, we educate our viewers on a disease that is only properly diagnosed and treated less than 20 percent of the time.

Although interstitial cystitis/bladder pain syndrome is estimated to impact 5.5 million women and men in the United States, many patients struggle to receive a diagnosis. Some patients report seeing doctors for up to 10 years before an IC/BPS diagnosis is received. Without a diagnosis, patients are unable to secure treatment. Health care professionals are often unfamiliar with IC/BPS, so they’re unclear on how to diagnose and treat it. The diagnostic approach needs to be simplified—look for pain, pressure, and/or discomfort and rule out other diseases.

Because of this, it is important that there is accurate information about IC/BPS available to both patients and HCPs, to increase awareness, provide the best path to diagnosis, and elevate the importance of this disease. Dr. Christopher Payne and his patient Stacy Carnazzo share their medical and personal experience with IC/BPS.

 

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments